[1] Mao YS, He J, Cheng GY. Current status of surgical management of esophageal cancer in China and the future strategy[J]. Zhonghua Zhong Liu Za Zhi, 2010, 32(6): 401-404.
[2] Ha M, Kim VN. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8): 509-524. DOI: 10.1038/nrm3838.
[3] Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research[J]. Nat Rev Cancer, 2010, 10(6): 389-402. DOI: 10.1038/nrc2867.
[4] Kohlhapp FJ, Mitra AK, Lengyel E, et al. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment[J]. Oncogene, 2015, 34(48): 5857-5868. DOI: 10.1038/onc.2015.89.
[5] Hong L, Han Y, Zhang H, et al. Prognosisrelated microRNAs in esophageal cancer[J]. Expert Opin Biol Ther, 2014, 14(4): 483-489. DOI: 10.1517/14712598.2014.882896.
[6] Huang J, Zhang SY, Gao YM, et al. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets[J]. Cell Prolif, 2014, 47(4): 277-286. DOI: 10.1111/cpr.12109.
[7] Wu BL, Xu LY, Du ZP, et al. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145[J]. World J Gastroenterol, 2011, 17(1): 79-88. DOI: 10.3748/wjg.v17.i1.79.
[8] Liu R, Liao J, Yang M, et al. The cluster of miR143 and miR145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1[J]. PLoS One, 2012, 7(3): e33987. DOI: 10.1371/journal.pone.0033987.
[9] Ni Y, Meng L, Wang L, et al. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma[J]. Gene, 2013, 517(2): 197-204. DOI: 10.1016/j.gene.2012.12.031.
[10] Ansari MH, Irani S, Edalat H, et al. Deregulation of miR-93 and miR-143 in human esophageal cancer[J]. Tumour Biol, 2016, 37(3): 3097-3103. DOI: 10.1007/s13277-015-3987-9.
[11] Clapé C, Fritz V, Henriquet C, et al. miR143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice[J]. PLoS One, 2009, 4(10): e7542. DOI: 10.1371/journal.pone.0007542.
[12] Xu B, Niu X, Zhang X, et al. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of K-RAS[J]. Mol Cell Biochem, 2011, 350(1/2): 207-213. DOI: 10.1007/s11010-010-0700-6.
[13] Zhou P, Chen WG, Li XW. MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer[J]. Am J Cancer Res, 2015, 5(6): 2056-2063.
[14] Xu YF, Li YQ, Guo R, et al. Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling[J]. Int J Biochem Cell Biol, 2015, 61: 120-128. DOI: 10.1016/j.biocel.2015.02.006.
[15] Zhai L, Ma C, Li W, et al. miR-143 suppresses epithelialmesenchymal transition and inhibits tumor growth of breast cancer through downregulation of ERK5[J]. Mol Carcinog, 2015: 22445. DOI: 10.1002/mc.22445.
[16] Wu XL, Cheng B, Li PY, et al. MicroRNA143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2[J]. World J Gastroenterol, 2013, 19(43): 7758-7765. DOI: 10.3748/wjg.v19.i43.7758.
[17] Zhuang M, Shi Q, Zhang X, et al. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2[J]. Tumour Biol, 2015, 36(4): 2737-2745. DOI: 10.1007/s13277-014-2898-5.
[18] Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting K-RAS in colorectal tumorigenesis[J]. Oncogene, 2009, 28(10): 1385-1392. DOI: 10.1038/onc.2008.474.
[19] Su J, Liang H, Yao W, et al. MiR-143 and miR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer[J]. PLoS One, 2014, 9(12): e114420. DOI: 10.1371/journal.pone.0114420.
[20] Osaki M, Takeshita F, Sugimoto Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression[J]. Mol Ther, 2011, 19(6): 11231130. DOI: 10.1038/mt.2011.53.
[21] Song T, Zhang X, Wang C, et al. Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase2[J]. Asian Pac J Cancer Prev, 2011, 12(4): 929933.
[22] Von Karstedt S, Conti A, Nobis M, et al. Cancer cellautonomous TRAILR signaling promotes KRASdriven cancer progression, invasion, and metastasis[J]. Cancer Cell, 2015, 27(4): 561-573. DOI: 10.1016/j.ccell.2015.02.014.
[23] Radojicic J, Zaravinos A, Spandidos DA. HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamouscell carcinoma carcinogenesis[J]. Int J Biol Markers, 2012, 27(1): 1-12. DOI: 10.5301/JBM.2011.8737. |